Neurogene
Nanette Cabaccang has extensive experience in accounting and finance, with their most recent position as an Accounting Manager at Neurogene Inc. starting in January 2023. Prior to that, they worked as an Accounting Professional at Hepion Pharmaceuticals from May 2021 to January 2023. Nanette also served as a Corporate Reporting Accountant, CPA at Integra LifeSciences from January 2015 to February 2017. Nanette had previous roles as a Senior Associate, CPA at CohnReznick from January 2011 to December 2014, and as a Staff Accountant at Samuel Klein & Co. from April 2008 to December 2010.
Nanette Cabaccang completed their Bachelor's degree in Accounting from Ferris State University, spanning from 2004 to 2007. In addition to their degree, they obtained various certifications throughout their career. These include the certification as a Certified Public Accountant from New Jersey in November 2009. More recently, they have obtained several certifications from Workiva, such as "Turning 2023 Uncertainty into Opportunities for CFOs and Controllers" in April 2023, "Connected Through Learning | Using the SEC Solution" in September 2022, "Workiva Platform Certification" in September 2022, "Connected Through Learning | Workiva Platform" in May 2022, and "Workiva Platform: Prepare" in May 2022.
Neurogene
Neurogene was founded to bring life-changing medicines to patients and families affected by rare neurological disorders. We partner with leading academic researchers, patient advocacy organizations and caregivers to bring to patients therapies that address the underlying genetic cause of a broad spectrum of neurological diseases where no effective treatment options exist today. Our lead programs use AAV-based gene therapy technology to deliver a normal gene to patients with a dysfunctional gene. Neurogene is also investing in novel technology to develop treatments for diseases not well served by gene therapy.